HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.

AbstractPURPOSE:
To report a clinical case of a patient with severe scleritis associated with rheumatoid arthritis (RA) refractive to conventional treatment that was treated effectively with rituximab.
METHODS AND RESULTS:
A 55-year-old man with RA, on etanercept and oral methotrexate, was referred with diagnosis of acute stromal keratitis, anterior uveitis, and anterior nodular scleritis in his right eye. Cyclophosphamide induced complete regression of acute stromal keratitis and anterior uveitis, but scleritis was still active and persistent. After two 1000-mg infusions of rituximab, scleritis regressed completely and is still in remission 9 months after the second rituximab infusion, without any concomitant use of oral steroids.
CONCLUSION:
Rituximab may be a treatment alternative in severe scleritis that is refractive to conventional therapy. Considering its safety profile, further studies are needed to refine its mechanism of action, optimal indications, and dosing in ocular inflammation.
AuthorsBarbara Iaccheri, Sofia Androudi, Elena Bartoloni Bocci, Roberto Gerli, Carlo Cagini, Tito Fiore
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) Vol. 18 Issue 3 Pg. 223-5 (Jun 2010) ISSN: 1744-5078 [Electronic] England
PMID20482403 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
Topics
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage, therapeutic use)
  • Antirheumatic Agents (administration & dosage, therapeutic use)
  • Arthritis, Rheumatoid (complications)
  • Dose-Response Relationship, Drug
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Remission Induction
  • Rituximab
  • Scleritis (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: